{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:01:55Z","timestamp":1790895715046,"version":"4.1.0"},"reference-count":169,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ejogrb.2020.05.054","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T11:33:45Z","timestamp":1591616025000},"page":"502-525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["British Gynaecological Cancer Society (BGCS) vulval cancer guidelines: Recommendations for practice"],"prefix":"10.1016","volume":"252","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0000-520X","authenticated-orcid":false,"given":"Jo","family":"Morrison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Cogswell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine","family":"Edey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Faruqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raji","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0039-5041","authenticated-orcid":false,"given":"Marcia","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Hillaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Rolland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Fotopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2020.05.054_bib0005","series-title":"Ano-uro-genital mucosal melanoma. Full guideline: melanoma focus","author":"Gore","year":"2018"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0010","unstructured":"Cancer Research UK. Vulval Cancer Incidence [Available from: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/vulval-cancer\/incidence."},{"issue":"6","key":"10.1016\/j.ejogrb.2020.05.054_bib0015","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/1471-0528.12459","article-title":"Vulval cancer incidence, mortality and survival in England: age-related trends","volume":"121","author":"Lai","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0020","doi-asserted-by":"crossref","DOI":"10.1158\/1055-9965.EPI-16-0019","article-title":"Lichen sclerosus: incidence and risk of vulvar squamous cell carcinoma","author":"Bleeker","year":"2016","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0025","unstructured":"Cancer Research UK. Vulval Cancer Mortality Data [Available from: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/vulval-cancer\/mortality."},{"issue":"5","key":"10.1016\/j.ejogrb.2020.05.054_bib0030","doi-asserted-by":"crossref","first-page":"e0128073","DOI":"10.1371\/journal.pone.0128073","article-title":"Incidence patterns and temporal trends of invasive nonmelanotic vulvar tumors in Germany 1999\u20132011. A population-based cancer registry analysis","volume":"10","author":"Buttmann-Schweiger","year":"2015","journal-title":"PLoS One"},{"issue":"21-22","key":"10.1016\/j.ejogrb.2020.05.054_bib0035","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00508-017-1255-2","article-title":"HPV prevalence in vulvar cancer in Austria","volume":"129","author":"Pils","year":"2017","journal-title":"Wien Klin Wochenschr"},{"issue":"11","key":"10.1016\/j.ejogrb.2020.05.054_bib0040","article-title":"Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in males and females","author":"Bergman","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.ejogrb.2020.05.054_bib0045","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/jnci\/djp534","article-title":"Impact of human papillomavirus (HPV)-6\/11\/16\/18 vaccine on all HPV-associated genital diseases in young women","volume":"102","author":"Munoz","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.ejogrb.2020.05.054_bib0050","article-title":"Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors","author":"Arbyn","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0055","doi-asserted-by":"crossref","first-page":"e1401","DOI":"10.1136\/bmj.e1401","article-title":"Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data","volume":"344","author":"Joura","year":"2012","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ejogrb.2020.05.054_bib0060","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ygyno.2018.08.033","article-title":"SPERANZA project: HPV vaccination after treatment for CIN2+","volume":"151","author":"Ghelardi","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2020.05.054_bib0065","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ygyno.2005.02.012","article-title":"Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients","volume":"97","author":"van Seters","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0070","article-title":"Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia","volume":"1","author":"Lawrie","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.05.054_bib0075","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ygyno.2010.12.340","article-title":"Treatment of vulvar intraepithelial neoplasia with topical imiquimod: seven years median follow-up of a randomized clinical trial","volume":"121","author":"Terlou","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.ejogrb.2020.05.054_bib0080","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/1471-0528.15124","article-title":"Recurrence of vulval intraepithelial neoplasia following treatment with cidofovir or imiquimod: results from a multicentre, randomised, phase II trial (RT3VIN)","volume":"125","author":"Hurt","year":"2018","journal-title":"BJOG"},{"issue":"6","key":"10.1016\/j.ejogrb.2020.05.054_bib0085","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1001\/archderm.140.6.702","article-title":"Does treatment of vulvar lichen sclerosus influence its prognosis?","volume":"140","author":"Cooper","year":"2004","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.ejogrb.2020.05.054_bib0090","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/archderm.140.6.709","article-title":"Vulvar lichen sclerosus: effect of long-term topical application of a potent steroid on the course of the disease","volume":"140","author":"Renaud-Vilmer","year":"2004","journal-title":"Arch Dermatol"},{"issue":"10","key":"10.1016\/j.ejogrb.2020.05.054_bib0095","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jamadermatol.2015.0643","article-title":"Long-term management of adult vulvar lichen sclerosus: a prospective cohort study of 507 women","volume":"151","author":"Lee","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.05.054_bib0100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/CJI.0000000000000148","article-title":"Sequencing treatment in BRAFV600 mutant melanoma: anti-PD-1 before and after BRAF inhibition","volume":"40","author":"Johnson","year":"2017","journal-title":"J Immunother."},{"issue":"5","key":"10.1016\/j.ejogrb.2020.05.054_bib0105","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ejca.2008.11.037","article-title":"Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age","volume":"45","author":"van de Nieuwenhof","year":"2009","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2020.05.054_bib0110","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/LGT.0b013e31818b8c13","article-title":"Vulvar cancer and the need for awareness of precursor lesions","volume":"13","author":"Maclean","year":"2009","journal-title":"J Low Genit Tract Dis"},{"issue":"6","key":"10.1016\/j.ejogrb.2020.05.054_bib0115","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/PGP.0000000000000375","article-title":"HPV-independent differentiated vulvar intraepithelial neoplasia (dVIN) is associated with an aggressive clinical course","volume":"36","author":"McAlpine","year":"2017","journal-title":"Int J Gynecol Pathol"},{"issue":"6","key":"10.1016\/j.ejogrb.2020.05.054_bib0120","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/PGP.0000000000000280","article-title":"The natural history of vulvar intraepithelial neoplasia, differentiated type: evidence for progression and diagnostic challenges","volume":"35","author":"Bigby","year":"2016","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"10.1016\/j.ejogrb.2020.05.054_bib0125","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/bjd.16241","article-title":"British Association of Dermatologists guidelines for the management of lichen sclerosus","volume":"178","author":"Lewis","year":"2018","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.ejogrb.2020.05.054_bib0130","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ijgo.12818","article-title":"Relationship between vulvar symptoms and incidence of vulvar cancer in women referred to a rapid access clinic","volume":"145","author":"Wiggans","year":"2019","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0135","series-title":"Suspected cancer: recognition and referral. NICE guideline [NG12] National Collaborating Centre for Cancer","author":"National Insitute for Health and Care Excellence","year":"2015"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0140","series-title":"Colposcopy programme and management. Guidelines for the NHS cervical screening programme","author":"Tidy","year":"2016"},{"issue":"2","key":"10.1016\/j.ejogrb.2020.05.054_bib0145","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ygyno.2012.07.118","article-title":"Vulvar intraepithelial neoplasia (VIN 2\/3): comparing clinical outcomes and evaluating risk factors for recurrence","volume":"127","author":"Wallbillich","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2020.05.054_bib0150","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4251\/wjgo.v9.i2.50","article-title":"Anal intraepithelial neoplasia: a review of diagnosis and management","volume":"9","author":"Roberts","year":"2017","journal-title":"World J Gastrointest Oncol"},{"issue":"3 Suppl. 1","key":"10.1016\/j.ejogrb.2020.05.054_bib0155","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/LGT.0000000000000117","article-title":"Screening for anal cancer in women","volume":"19","author":"Moscicki","year":"2015","journal-title":"J Low Genit Tract Dis"},{"issue":"Suppl. 4","key":"10.1016\/j.ejogrb.2020.05.054_bib0160","first-page":"A14","article-title":"Radiotherapy instead of inguinofemoral lymphadenectomy in vulvar cancer patients with a metastatic sentinel node: results of GROINSS-V II","volume":"29","author":"Oonk","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2020.05.054_bib0165","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/AOG.0000000000001285","volume":"127","author":"Bornstein","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ejogrb.2020.05.054_bib0170","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/00000478-200405000-00012","article-title":"Vulvar acanthosis with altered differentiation: a precursor to verrucous carcinoma?","volume":"28","author":"Nascimento","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.ejogrb.2020.05.054_bib0175","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijgo.2014.02.003","article-title":"FIGO staging for carcinoma of the vulva, cervix, and corpus uteri","volume":"125","author":"FIGO Committee on Gynecologic Oncology","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0180","series-title":"Dataset for histopathological reporting of vulval carcinomas","author":"Faruqi","year":"2018"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.05.054_bib0185","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0090-8258(88)90267-3","article-title":"Prognostic factors in early vulvar cancer","volume":"31","author":"Rowley","year":"1988","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.ejogrb.2020.05.054_bib0190","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/PAS.0000000000000422","article-title":"Perineural invasion is an independent pathologic Indicator of recurrence in vulvar squamous cell carcinoma","volume":"39","author":"Holthoff","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.ejogrb.2020.05.054_bib0195","first-page":"397","article-title":"Vulval squamous cell carcinoma occurring on a background of differentiated vulval intraepithelial neoplasia is more likely to recur: a review of 154 cases","volume":"53","author":"Eva","year":"2008","journal-title":"J Reprod Med"},{"issue":"3","key":"10.1016\/j.ejogrb.2020.05.054_bib0200","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ygyno.2016.06.019","article-title":"Adjacent Lichen Sclerosis predicts local recurrence and second field tumour in women with vulvar squamous cell carcinoma","volume":"142","author":"Yap","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2020.05.054_bib0205","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/his.13205","article-title":"Human papillomavirus (HPV)-independent vulvar squamous cell carcinoma has a worse prognosis than HPV-associated disease: a retrospective cohort study","volume":"71","author":"McAlpine","year":"2017","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.05.054_bib0210","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ygyno.2018.10.015","article-title":"The prognostic value of p16 and p53 expression for survival after vulvar cancer: a systematic review and meta-analysis","volume":"152","author":"Sand","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.ejogrb.2020.05.054_bib0215","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S1470-2045(10)70104-2","article-title":"Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study","volume":"11","author":"Oonk","year":"2010","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ejogrb.2020.05.054_bib0220","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/IGC.0000000000000975","article-title":"European society of gynaecological oncology guidelines for the management of patients with vulvar cancer","volume":"27","author":"Oonk","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2020.05.054_bib0225","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00000478-200203000-00013","article-title":"Recommendations for sentinel lymph node processing in breast cancer","volume":"26","author":"Yared","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.ejogrb.2020.05.054_bib0230","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1200\/JCO.2007.14.0566","article-title":"Sentinel node dissection is safe in the treatment of early-stage vulvar cancer","volume":"26","author":"Van der Zee","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.05.054_bib0235","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ygyno.2018.10.007","article-title":"Sentinel lymph node (SLN) concept in cervical cancer: current limitations and unanswered questions","volume":"152","author":"Cibula","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"11","key":"10.1016\/j.ejogrb.2020.05.054_bib0240","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/PAS.0b013e3181b40081","article-title":"HPV-negative vulvar intraepithelial neoplasia (VIN) with basaloid histologic pattern: an unrecognized variant of simplex (differentiated) VIN","volume":"33","author":"Ordi","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.ejogrb.2020.05.054_bib0245","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/PGP.0000000000000509","article-title":"Classic vulvar intraepithelial neoplasia with superimposed lichen simplex chronicus: a unique variant mimicking differentiated vulvar intraepithelial neoplasia","volume":"38","author":"Watkins","year":"2019","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"10.1016\/j.ejogrb.2020.05.054_bib0250","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00000478-200003000-00013","article-title":"Vulvar intraepithelial neoplasia of the simplex (differentiated) type: a clinicopathologic study including analysis of HPV and p53 expression","volume":"24","author":"Yang","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.05.054_bib0255","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/PAS.0000000000000291","article-title":"Expanding the morphologic spectrum of differentiated VIN (dVIN) through detailed mapping of cases with p53 loss","volume":"39","author":"Singh","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.ejogrb.2020.05.054_bib0260","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/PGP.0000000000000317","article-title":"Assessment of CK17 as a marker for the diagnosis of differentiated vulvar intraepithelial neoplasia","volume":"36","author":"Podoll","year":"2017","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0265","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.critrevonc.2016.03.008","article-title":"Paget disease of the vulva","volume":"101","author":"van der Linden","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0270","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-2018-000080","article-title":"Reviewing vulvar Paget\u2019s disease molecular bases. Looking forward to personalized target therapies: a matter of CHANGE","author":"Mantovani","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.05.054_bib0275","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ogc.2018.09.008","article-title":"Vulvar cancer","volume":"46","author":"Weinberg","year":"2019","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"6","key":"10.1016\/j.ejogrb.2020.05.054_bib0280","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/IGC.0b013e3182980ffb","article-title":"Vulvar\/vaginal melanoma: an updated surveillance epidemiology and end results database review, comparison with cutaneous melanoma and significance of racial disparities","volume":"23","author":"Mert","year":"2013","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"10.1016\/j.ejogrb.2020.05.054_bib0285","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/cncr.30473","article-title":"Vulvar and vaginal melanoma: a unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma","volume":"123","author":"Hou","year":"2017","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2020.05.054_bib0290","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"10.1016\/j.ejogrb.2020.05.054_bib0295","first-page":"574","article-title":"Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions","volume":"58","author":"Hacker","year":"1981","journal-title":"Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.ejogrb.2020.05.054_bib0300","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.ejso.2014.03.027","article-title":"Impact of radical operative treatment on the quality of life in women with vulvar cancer--a retrospective study","volume":"40","author":"Gunther","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejogrb.2020.05.054_bib0305","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/cncr.10969","article-title":"Vulvar carcinoma. The price of less radical surgery","volume":"95","author":"De Hullu","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0310","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1245\/s10434-011-1778-0","article-title":"Prognostic value of pathological resection margin distance in squamous cell cancer of the vulva","volume":"18","author":"Woelber","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2020.05.054_bib0315","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/1758834012471699","article-title":"Management of patients with vulvar cancer: a perspective review according to tumour stage","volume":"5","author":"Woelber","year":"2013","journal-title":"Ther Adv Med Oncol"},{"issue":"10","key":"10.1016\/j.ejogrb.2020.05.054_bib0320","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.ejso.2018.05.031","article-title":"Surgical margins in squamous cell carcinoma, different for the vulva?","volume":"44","author":"Pleunis","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejogrb.2020.05.054_bib0325","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.ejso.2019.07.005","article-title":"Surgical treatment of vulvar cancer: impact of tumor-free margin distance on recurrence and survival. A multicentre cohort analysis from the francogyn study group","volume":"45","author":"Raimond","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0330","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejca.2016.09.038","article-title":"Role of tumour-free margin distance for loco-regional control in vulvar cancer\u2014a subset analysis of the Arbeitsgemeinschaft Gyn\u00e4kologische Onkologie CaRE-1 multicenter study","volume":"69","author":"Woelber","year":"2016","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2020.05.054_bib0335","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/IGC.0000000000001195","article-title":"The role of pathological margin distance and prognostic factors after primary surgery in squamous cell carcinoma of the vulva","volume":"28","author":"Arvas","year":"2018","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2020.05.054_bib0340","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ygyno.2017.11.006","article-title":"Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: a systematic review","volume":"148","author":"Te Grootenhuis","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ejogrb.2020.05.054_bib0345","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/IGC.0b013e3181a12fa2","article-title":"Differentiated-type vulval intraepithelial neoplasia has a high-risk association with vulval squamous cell carcinoma","volume":"19","author":"Eva","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2020.05.054_bib0350","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ygyno.2019.05.010","article-title":"Margin status revisited in vulvar squamous cell carcinoma","volume":"154","author":"te Grootenhuis","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ejogrb.2020.05.054_bib0355","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.3802\/jgo.2016.27.e60","article-title":"Surgical therapy of vulvar cancer: how to choose the correct reconstruction?","volume":"27","author":"Gentileschi","year":"2016","journal-title":"J Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.ejogrb.2020.05.054_bib0360","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1097\/IGC.0b013e318263ef55","article-title":"Tailoring the treatment of locally advanced squamous cell carcinoma of the vulva: neoadjuvant chemotherapy followed by radical surgery: results from a multicenter study","volume":"22","author":"Aragona","year":"2012","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.05.054_bib0365","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/gyno.1993.1163","article-title":"Cisplatin (P), bleomycin (B), and methotrexate (M) preoperative chemotherapy in locally advanced vulvar carcinoma","volume":"50","author":"Benedetti-Panici","year":"1993","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ejogrb.2020.05.054_bib0370","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.ijrobp.2012.11.012","article-title":"Preoperative intensity modulated radiation therapy and chemotherapy for locally advanced vulvar carcinoma: analysis of pattern of relapse","volume":"85","author":"Beriwal","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ejogrb.2020.05.054_bib0375","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/IGC.0b013e3181c93adc","article-title":"Neoadjuvant chemotherapy in advanced vulvar cancer","volume":"20","author":"Domingues","year":"2010","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.05.054_bib0380","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ygyno.2005.06.068","article-title":"Neoadjuvant chemotherapy in vulvar cancer: avoiding primary exenteration","volume":"100","author":"Geisler","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2020.05.054_bib0385","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1006\/gyno.2001.6180","article-title":"Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer","volume":"81","author":"Wagenaar","year":"2001","journal-title":"Gynecol Oncol."},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2017.06.005","article-title":"Bartholin gland cancer","volume":"117","author":"Di Donato","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"10.1016\/j.ejogrb.2020.05.054_bib0395","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/IGC.0000000000000656","article-title":"Carcinoma of the bartholin gland: a review of 33 cases","volume":"26","author":"Bhalwal","year":"2016","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2020.05.054_bib0400","first-page":"361","article-title":"Primary carcinoma of the Bartholin gland: a report of 14 cases and review of the literature","volume":"60","author":"Leuchter","year":"1982","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2020.05.054_bib0405","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/00006250-198606000-00009","article-title":"Bartholin gland carcinoma","volume":"67","author":"Copeland","year":"1986","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ejogrb.2020.05.054_bib0410","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00004347-199710000-00005","article-title":"Basal cell carcinoma of the vulva: a clinicopathologic study of 45 cases","volume":"16","author":"Feakins","year":"1997","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"10.1016\/j.ejogrb.2020.05.054_bib0415","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejso.2011.12.008","article-title":"Invasive extramammary Paget\u2019s disease and the risk for secondary tumours in Europe","volume":"38","author":"van der Zwan","year":"2012","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0420","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.gore.2016.12.010","article-title":"Paget\u2019s disease of the vulva: a review of 89 cases","volume":"19","author":"Onaiwu","year":"2017","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0425","series-title":"Green-top guideline No. 58: the management of vulval skin disorders","author":"Royal College of Obstetricians and Gynaecologists","year":"2011"},{"issue":"6","key":"10.1016\/j.ejogrb.2020.05.054_bib0430","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/bjd.16894","article-title":"Stop routine screening for associated malignancies in cutaneous noninvasive vulvar Paget disease?","volume":"179","author":"van der Linden","year":"2018","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.ejogrb.2020.05.054_bib0435","article-title":"Interventions for the treatment of Paget\u2019s disease of the vulva","author":"Edey","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ejogrb.2020.05.054_bib0440","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/IGC.0000000000000901","article-title":"Paget\u2019s disease of the vulva: a review of 20 years\u2019 experience","volume":"27","author":"Parashurama","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.05.054_bib0445","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ygyno.2015.07.097","article-title":"Effects of imiquimod on vulvar Paget\u2019s disease: a systematic review of literature","volume":"139","author":"Machida","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0450","series-title":"Guidelines for the diagnosis and management of vulval carcinoma","author":"Royal College of Obstetricians and Gynaecologists","year":"2014"},{"issue":"5","key":"10.1016\/j.ejogrb.2020.05.054_bib0455","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/00000658-197011000-00017","article-title":"Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma","volume":"172","author":"Breslow","year":"1970","journal-title":"Ann Surg"},{"issue":"7","key":"10.1016\/j.ejogrb.2020.05.054_bib0460","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/IGC.0000000000000768","article-title":"Prognostic factors of recurrence and survival in vulvar melanoma: subgroup analysis of the VULvar CANcer study","volume":"26","author":"Iacoponi","year":"2016","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.ejogrb.2020.05.054_bib0465","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jaad.2011.11.921","article-title":"Clinicopathologic study of 85 cases of melanoma of the female genitalia","volume":"67","author":"Tcheung","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0470","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.14694\/EdBook_AM.2014.34.e277","article-title":"Management of vulvar and vaginal melanomas: current and future strategies","author":"Leitao","year":"2014","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0475","series-title":"Nivolumab for adjuvant treatment of completely resected melanoma with lymph node involvement or metastatic disease","author":"National Insitute for Health and Care Excellence","year":"2019"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0480","series-title":"Nivolumab for adjuvant treatment of completely resected melanoma with lymph node involvement or metastatic disease. Technology appraisal guidance 558","author":"National Insitute for Health and Care Excellence","year":"2019"},{"issue":"4","key":"10.1016\/j.ejogrb.2020.05.054_bib0485","first-page":"408","article-title":"Management of regional lymph nodes and their prognostic influence in vulvar cancer","volume":"61","author":"Hacker","year":"1983","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2020.05.054_bib0490","first-page":"402","article-title":"Prognostic significance of groin lymph node metastases in squamous carcinoma of the vulva","volume":"66","author":"Hoffman","year":"1985","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.05.054_bib0495","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/ijgc-00009577-200601000-00050","article-title":"Routine computerized tomography scanning, groin ultrasound with or without fine needle aspiration cytology in the surgical management of primary squamous cell carcinoma of the vulva","volume":"16","author":"Land","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0500","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1471-0528.1960.tb09245.x","article-title":"Lymphatics of the vulva","volume":"67","author":"Parry-Jones","year":"1960","journal-title":"J Obstet Gynaecol Br Emp"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0505","series-title":"Improving outcomes in gynaecological cancer - the research evidence","author":"Melville","year":"1999"},{"issue":"9","key":"10.1016\/j.ejogrb.2020.05.054_bib0510","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1136\/ijgc-2019-000798","article-title":"Sentinel lymph node consensus document of the British Gynaecological Cancer society for endometrial, vulvar, and cervical cancers","volume":"29","author":"Fotopoulou","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.05.054_bib0515","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/IGC.0000000000000860","article-title":"Groin recurrences in node negative vulvar cancer patients after sole sentinel lymph node dissection","volume":"27","author":"Klapdor","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"12","key":"10.1016\/j.ejogrb.2020.05.054_bib0520","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1038\/bjc.2014.205","article-title":"Sentinel lymph node biopsy in vulval cancer: systematic review and meta-analysis","volume":"110","author":"Meads","year":"2014","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.05.054_bib0525","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ygyno.2013.04.023","article-title":"Lymphatic mapping and sentinel node biopsy in squamous cell carcinoma of the vulva: systematic review and meta-analysis of the literature","volume":"130","author":"Hassanzade","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2020.05.054_bib0530","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ygyno.2010.10.009","article-title":"Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results","volume":"120","author":"Crane","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ejogrb.2020.05.054_bib0535","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/IGC.0000000000000419","article-title":"Sentinel lymph node biopsy in vulvar cancer using combined radioactive and fluorescence guidance","volume":"25","author":"Verbeek","year":"2015","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"10.1016\/j.ejogrb.2020.05.054_bib0540","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1038\/bjc.2013.631","article-title":"Cost-effectiveness of sentinel lymph node biopsy vs inguinofemoral lymphadenectomy in women with vulval cancer","volume":"109","author":"Sutton","year":"2013","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2020.05.054_bib0545","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/sj.bjc.6602343","article-title":"The prognostic significance of micrometastases in node-negative squamous cell carcinoma of the vulva","volume":"92","author":"Narayansingh","year":"2005","journal-title":"Br J Cancer"},{"issue":"8","key":"10.1016\/j.ejogrb.2020.05.054_bib0550","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1245\/s10434-016-5114-6","article-title":"The risk of contralateral non-sentinel metastasis in patients with primary vulvar cancer and unilaterally positive sentinel node","volume":"23","author":"Woelber","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.05.054_bib0555","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ygyno.2015.09.077","article-title":"Sentinel nodes in vulvar cancer: long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I","volume":"140","author":"Te Grootenhuis","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2020.05.054_bib0560","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/IGC.0000000000000637","article-title":"Should groin recurrence still Be considered as a palliative situation in vulvar cancer patients? A brief report","volume":"26","author":"Frey","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0565","doi-asserted-by":"crossref","DOI":"10.1111\/1471-0528.15341","article-title":"The efficacy of ultrasound in the follow up after a negative sentinel lymph node in women with vulvar cancer: a prospective single-centre study","author":"Pouwer","year":"2018","journal-title":"Bjog"},{"issue":"5","key":"10.1016\/j.ejogrb.2020.05.054_bib0570","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/0002-9378(87)90132-3","article-title":"Positive groin lymph nodes in superficial squamous cell vulvar cancer. A Gynecologic Oncology Group Study","volume":"156","author":"Sedlis","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0575","series-title":"The impact of saphenous vein sparing during inguinal lymphadenectomy on postoperative morbidity in women with vulval cancer: an updated per-groin meta-analysis of short-term outcomes","author":"Tranoulis","year":"2018"},{"issue":"7","key":"10.1016\/j.ejogrb.2020.05.054_bib0580","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/1097-0142(20001001)89:7<1520::AID-CNCR15>3.0.CO;2-N","article-title":"Preservation of the saphenous vein during inguinal lymphadenectomy decreases morbidity in patients with carcinoma of the vulva","volume":"89","author":"Zhang","year":"2000","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ejogrb.2020.05.054_bib0585","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejso.2013.02.012","article-title":"Does the count after inguinofemoral lymphadenectomy in vulvar cancer correlate with outcome?","volume":"39","author":"Baiocchi","year":"2013","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejogrb.2020.05.054_bib0590","first-page":"510","article-title":"Isolated groin recurrence in vulval squamous cell cancer (VSCC). The importance of node count","volume":"31","author":"Butler","year":"2010","journal-title":"Eur J Gynaecol Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2020.05.054_bib0595","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ygyno.2010.01.007","article-title":"Does the number of nodes removed impact survival in vulvar cancer patients with node-negative disease?","volume":"117","author":"Courtney-Brooks","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ejogrb.2020.05.054_bib0600","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/IGC.0000000000000125","article-title":"Lymph node count at inguinofemoral lymphadenectomy and groin recurrences in vulvar cancer","volume":"24","author":"van Beekhuizen","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2020.05.054_bib0605","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0090-8258(92)90247-G","article-title":"A matched comparison of single and triple incision techniques for the surgical treatment of carcinoma of the vulva","volume":"46","author":"Helm","year":"1992","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ejogrb.2020.05.054_bib0610","first-page":"490","article-title":"Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group","volume":"79","author":"Stehman","year":"1992","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2020.05.054_bib0615","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0090-8258(92)90311-6","article-title":"Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva stage III and IVA FIGO","volume":"45","author":"Origoni","year":"1992","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.ejogrb.2020.05.054_bib0620","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1002\/1097-0142(19941101)74:9<2491::AID-CNCR2820740916>3.0.CO;2-5","article-title":"Prognostic significance of lymph node variables in squamous cell carcinoma of the vulva","volume":"74","author":"Paladini","year":"1994","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2020.05.054_bib0625","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/IGC.0b013e31823eed4c","article-title":"Prognostic role of lymph node metastases in vulvar cancer and implications for adjuvant treatment","volume":"22","author":"Woelber","year":"2012","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.05.054_bib0630","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1525-1438.2006.00769.x","article-title":"Squamous cell carcinoma of the vulva with bulky positive groin nodes-nodal debulking versus full groin dissection prior to radiation therapy","volume":"17","author":"Hyde","year":"2007","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2020.05.054_bib0635","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ygyno.2015.09.081","article-title":"Groin surgery and risk of recurrence in lymph node positive patients with vulvar squamous cell carcinoma","volume":"139","author":"Nooij","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2020.05.054_bib0640","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju426","article-title":"Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study","volume":"107","author":"Mahner","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.ejogrb.2020.05.054_bib0645","first-page":"733","article-title":"Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes","volume":"68","author":"Homesley","year":"1986","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2020.05.054_bib0650","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ygyno.2017.06.004","article-title":"Lymphedema following gynecological cancer: results from a prospective, longitudinal cohort study on prevalence, incidence and risk factors","volume":"146","author":"Hayes","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.05.054_bib0655","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/igc.0000000000001146","article-title":"Do groin drains reduce postoperative morbidity in women undergoing inguinofemoral lymphadenectomy for vulvar cancer?","volume":"28","author":"Pontre","year":"2018","journal-title":"Int J Gynecol Cancer"},{"issue":"11","key":"10.1016\/j.ejogrb.2020.05.054_bib0660","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010933","article-title":"Wound drainage following groin dissection for malignant disease in adults","author":"Thomson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.05.054_bib0665","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ygyno.2008.03.005","article-title":"A randomized phase III trial of VH fibrin sealant to reduce lymphedema after inguinal lymph node dissection: a Gynecologic Oncology Group study","volume":"110","author":"Carlson","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.05.054_bib0670","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2004.07.022","article-title":"A prospective, randomized study analyzing sartorius transposition following inguinal-femoral lymphadenectomy","volume":"95","author":"Judson","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ejogrb.2020.05.054_bib0675","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/02841868409136031","article-title":"Treatment of recurrent squamous cell carcinoma of the vulva","volume":"23","author":"Simonsen","year":"1984","journal-title":"Acta Radiol Oncol"},{"issue":"6","key":"10.1016\/j.ejogrb.2020.05.054_bib0680","article-title":"Negative pressure wound therapy for treating surgical wounds healing by secondary intention","author":"Dumville","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.ejogrb.2020.05.054_bib0685","article-title":"Negative pressure wound therapy for surgical wounds healing by primary closure","author":"Norman","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.05.054_bib0690","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijrobp.2016.09.023","article-title":"Adjuvant radiation therapy for margin-positive vulvar squamous cell carcinoma: defining the ideal dose-response using the national cancer data base","volume":"97","author":"Chapman","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ejogrb.2020.05.054_bib0695","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00432-015-2060-9","article-title":"Adjuvant radiotherapy for vulvar cancer with close or positive surgical margins","volume":"142","author":"Ignatov","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejogrb.2020.05.054_bib0700","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ijrobp.2005.11.007","article-title":"Intensity-modulated radiotherapy for the treatment of vulvar carcinoma: a comparative dosimetric study with early clinical outcome","volume":"64","author":"Beriwal","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ejogrb.2020.05.054_bib0705","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.ijrobp.2016.02.043","article-title":"Consensus recommendations for radiation therapy contouring and treatment of vulvar carcinoma","volume":"95","author":"Gaffney","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ejogrb.2020.05.054_bib0710","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ygyno.2013.05.036","article-title":"Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma","volume":"130","author":"Viswanathan","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2020.05.054_bib0715","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ygyno.2015.03.056","article-title":"Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: a National Cancer Data Base (NCDB) analysis","volume":"137","author":"Gill","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2020.05.054_bib0720","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ygyno.2011.11.003","article-title":"A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study","volume":"124","author":"Moore","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ejogrb.2020.05.054_bib0725","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1080\/02841860701843050","article-title":"Is it beneficial to selectively boost high-risk tumor subvolumes? A comparison of selectively boosting high-risk tumor subvolumes versus homogeneous dose escalation of the entire tumor based on equivalent EUD plans","volume":"47","author":"Kim","year":"2008","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0730","series-title":"A phase II trial evaluating cisplatin (NSC #119875) and Gemcitabine (NSC #613327) concurrent with intensity-modulated radiation therapy (IMRT) in the treatment of locally advanced squamous cell carcinoma of the vulva (NCT #01595061)2018 11 nov 2018","author":"Horowitz","year":"2018"},{"issue":"3","key":"10.1016\/j.ejogrb.2020.05.054_bib0735","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0090-8258(90)90367-T","article-title":"Bleomycin, methotrexate, and CCNU in advanced inoperable squamous cell carcinoma of the vulva: a phase II study of the EORTC Gynaecological Cancer cooperative Group (GCCG)","volume":"37","author":"Durrant","year":"1990","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ejogrb.2020.05.054_bib0740","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/IGC.0b013e31824b4058","article-title":"Weekly paclitaxel\/carboplatin in the treatment of locally advanced, recurrent, or metastatic vulvar cancer","volume":"22","author":"Han","year":"2012","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.05.054_bib0745","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3802\/jgo.2014.25.1.22","article-title":"Role of paclitaxel and cisplatin as the neoadjuvant treatment for locally advanced squamous cell carcinoma of the vulva","volume":"25","author":"Raspagliesi","year":"2014","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.05.054_bib0750","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0360-3016(98)00193-X","article-title":"Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group","volume":"42","author":"Moore","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.ejogrb.2020.05.054_bib0755","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1159\/000487435","article-title":"Brief report on 3-Weekly paclitaxel carboplatin efficacy in locally advanced or metastatic squamous vulvar cancer","volume":"83","author":"Amant","year":"2018","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0760","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejogrb.2017.03.030","article-title":"Neoadjuvant and definitive chemotherapy or chemoradiation for stage III and IV vulvar cancer: a pooled Reanalysis","volume":"212","author":"Forner","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"10.1016\/j.ejogrb.2020.05.054_bib0765","article-title":"Chemoradiation for advanced primary vulval cancer","author":"Shylasree","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0770","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-00009577-200303001-00019","article-title":"Randomised study between neoadjuvant chemoradiotherapy and primary surgery for the treatment of advanced vulvar cancer","volume":"13","author":"Maneo","year":"2003","journal-title":"Int J Gynecol Cancer"},{"issue":"9","key":"10.1016\/j.ejogrb.2020.05.054_bib0775","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/annonc\/mdw242","article-title":"The forgotten woman\u2019s cancer: vulvar squamous cell carcinoma (VSCC) and a targeted approach to therapy","volume":"27","author":"Clancy","year":"2016","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.05.054_bib0780","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ygyno.2012.06.028","article-title":"Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva","volume":"127","author":"Horowitz","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0785","first-page":"1","article-title":"Pembrolizumab in recurrent squamous cell carcinoma of the vulva: case report and review of the literature","volume":"17","author":"Shields","year":"2018","journal-title":"Gynecol Obstet Invest"},{"issue":"9","key":"10.1016\/j.ejogrb.2020.05.054_bib0790","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/annonc\/mdp043","volume":"20","author":"Witteveen","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0795","series-title":"1 study of Durvalumab, tremelimumab and radiotherapy in recurrent gynecologic Cancer [Internet]. ClinicalTrials.gOv.","author":"Phase","year":"2017"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0800","series-title":"Pilot study on concurrent cisplatin-based chemotherapy combined with vaccination therapy with the P16_37-63 peptide in patients with HPV- and p16INK4a-positive Cancer [Internet]","year":"2015"},{"issue":"28","key":"10.1016\/j.ejogrb.2020.05.054_bib0805","doi-asserted-by":"crossref","first-page":"46204","DOI":"10.18632\/oncotarget.17581","article-title":"Local immune response depends on p16INK4a status of primary tumor in vulvar squamous cell carcinoma","volume":"8","author":"Sznurkowski","year":"2017","journal-title":"Oncotarget"},{"issue":"46","key":"10.1016\/j.ejogrb.2020.05.054_bib0810","doi-asserted-by":"crossref","first-page":"e8722","DOI":"10.1097\/MD.0000000000008722","article-title":"Incidence of lower limb lymphedema after vulvar cancer: a systematic review and meta-analysis","volume":"96","author":"Huang","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.05.054_bib0815","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/IGC.0000000000000311","article-title":"The effect of groin treatment modality and sequence on clinically significant chronic lymphedema in patients with vulvar carcinoma","volume":"25","author":"Berger","year":"2015","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.ejogrb.2020.05.054_bib0820","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/micr.30115","article-title":"Do surgical interventions for limb lymphoedema reduce cellulitis attack frequency?","volume":"37","author":"Sharkey","year":"2017","journal-title":"Microsurgery"},{"issue":"3","key":"10.1016\/j.ejogrb.2020.05.054_bib0825","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1188\/14.ONF.297-306","article-title":"Supportive care needs after gynecologic cancer: where does sexual health fit in?","volume":"41","author":"McCallum","year":"2014","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0830","series-title":"Macmillan Cancer Support. Part 1: guidelines on late effects of gynaecological cancer: pelvic radiotherapy","year":"2014"},{"issue":"2","key":"10.1016\/j.ejogrb.2020.05.054_bib0835","article-title":"Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers","volume":"2017","author":"Lawrie","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.ejogrb.2020.05.054_bib0840","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/ijgc-2019-001176","article-title":"British Gynaecological Cancer society recommendations and guidance on patient-initiated follow-up (PIFU)","volume":"30","author":"Newton","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2020.05.054_bib0845","series-title":"Suspected cancer: recognition and referral. NICE guideline [NG12]","author":"National Insitute for Health and Care Excellence","year":"2017"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211520303389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211520303389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:53:15Z","timestamp":1759557195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211520303389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":169,"alternative-id":["S0301211520303389"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2020.05.054","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"British Gynaecological Cancer Society (BGCS) vulval cancer guidelines: Recommendations for practice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2020.05.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}